120 related articles for article (PubMed ID: 27805424)
1. Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay.
Dengler M; Huber H; Müller CJ; Zellmer A; Rauch P; Mikulits W
Assay Drug Dev Technol; 2016 Nov; 14(9):543-550. PubMed ID: 27805424
[TBL] [Abstract][Full Text] [Related]
2. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
[TBL] [Abstract][Full Text] [Related]
3. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
4. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
Ekman C; Stenhoff J; Dahlbäck B
J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
[TBL] [Abstract][Full Text] [Related]
5. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
[TBL] [Abstract][Full Text] [Related]
7. The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.
Staufer K; Dengler M; Huber H; Marculescu R; Stauber R; Lackner C; Dienes HP; Kivaranovic D; Schachner C; Zeitlinger M; Wulkersdorfer B; Rauch P; Prager G; Trauner M; Mikulits W
Cell Death Dis; 2017 Oct; 8(10):e3135. PubMed ID: 29072690
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of soluble Axl in acute coronary syndrome.
Liu YW; Yang QF; Zuo PY; Xiao CL; Chen XL; Liu CY
Am J Med Sci; 2015 Feb; 349(2):124-9. PubMed ID: 25474223
[TBL] [Abstract][Full Text] [Related]
9. Soluble AXL as a marker of disease progression and survival in melanoma.
Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
Ekman C; Linder A; Akesson P; Dahlbäck B
Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of sAxl are associated with severe preeclampsia.
Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
[TBL] [Abstract][Full Text] [Related]
12. Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet's disease.
Baskol G; Yetkin MÖ; Sevim DG; Guclu K; Arda H; Saracoglu H; Gahramanov K; Evereklioglu C
Indian J Ophthalmol; 2024 May; 72(Suppl 3):S468-S472. PubMed ID: 38648454
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia.
Ko CP; Yu YL; Hsiao PC; Yang SF; Yeh CB
Mol Med Rep; 2014 Apr; 9(4):1400-4. PubMed ID: 24503651
[TBL] [Abstract][Full Text] [Related]
15. AXL receptor tyrosine kinase is increased in patients with heart failure.
Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
[TBL] [Abstract][Full Text] [Related]
16. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
Johansson G; Peng PC; Huang PY; Chien HF; Hua KT; Kuo ML; Chen CT; Lee MJ
PLoS One; 2014; 9(12):e115916. PubMed ID: 25551830
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
[TBL] [Abstract][Full Text] [Related]
18. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
[TBL] [Abstract][Full Text] [Related]
19. Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease.
Chen SC; Ko JL; Yang SF; Tsai MY; Tsai HT; Tang CH; Wang PH
Clin Chim Acta; 2013 Nov; 426():85-90. PubMed ID: 24045047
[TBL] [Abstract][Full Text] [Related]
20. Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.
Xu L; Hu F; Zhu H; Liu X; Shi L; Li Y; Zhong H; Su Y
Clin Exp Immunol; 2018 Apr; 192(1):95-103. PubMed ID: 29148078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
